The United States has come under fire for pressuring developing countries to give up their right to produce cheap, generic anti-AIDS medicines in return for bilateral trade agreements that strengthen protection of costlier, brand name drugs.

Nobel economics laureate Joseph Stiglitz joined advocacy groups Oxfam and Médecins Sans Frontières this month in criticising Washington for bowing to industry pressure by pursuing a policy the groups say could prevent millions of AIDS patients in …